Work

Financial Incentives for Adherence to Hepatitis C Virus Clinical Care and Treatment: A Randomized Trial of Two Strategies

Year: 2020

Type: article

Abstract: Although rates of sustained virologic response (SVR) after hepatitis C virus (HCV) treatment with direct-acting antivirals (DAAs) surpass 90% in trials and some more “real world” settings, some patients, such as those with substance use disorders, will be challenged to adhere to HCV care.

Source: Carolina Digital Repository (University of North Carolina at Chapel Hill)

DOI: 10.17615/97nw-k717

Authors: Straub, Becky, Mollan, Katie R., Hurt, Christopher, Wohl, David A., Allmon, Andrew G., Reifeis, Sarah Ailleen, Edwards, Angela, Thirumurthy, Harsha, Evon, Donna

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G3810609436, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

OpenAlex ID: W4301048501

FWCI:

Cites:

Cited by:

Related to: 10